We found that high ATOX1 levels in the tumor cell cytoplasm, but not ATOX1 in the nucleus, correlated with a trend towards better EFS when considering all breast cancer subtypes (i.e., Luminal, HER2 and TNBC) (Figure 4A,B). This evidence concerns the gene ATOX1 and neoplasm.